Complying with 21 CFR Part 11: A Guide for Regulated Life-Sciences Organizations

As FDA-regulated life sciences organizations face growing pressure to protect digital evidence and prove the integrity of electronic records and signatures, compliance with 21 CFR Part 11 has become a core operational requirement—not merely a documentation exercise. The regulation establishes a framework for validated systems, secure audit trails, access controls, identity verification, and tightly governed electronic signatures across the life cycle of regulated records, with heightened expectations around authenticity, integrity, traceability, and non-repudiation. Organizations must demonstrate that electronic records are trustworthy, signatures are uniquely tied to individuals, and system activity is continuously monitored and retained for inspection. This guide breaks down the regulation's essential requirements and shows how ManageEngine solutions help your organization implement, operationalize, and strengthen 21 CFR Part 11 compliance with confidence.

What you’ll learn

• What 21 CFR Part 11 covers and why it matters to FDA-regulated organizations.
• The difference between closed systems and open systems, and how the control expectations change.
• How secure audit trails, validation, access controls, and documentation governance support compliance.
• What electronic signature requirements mean in practice, including identity verification and two-factor components.
• How identity governance and security monitoring help strengthen records and signature oversight.